XTX Topco Ltd Acquires 14,420 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

XTX Topco Ltd raised its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 312.6% in the fourth quarter, Holdings Channel reports. The firm owned 19,033 shares of the company’s stock after purchasing an additional 14,420 shares during the period. XTX Topco Ltd’s holdings in Ryan Specialty were worth $1,221,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors have also recently made changes to their positions in the business. JPMorgan Chase & Co. increased its holdings in Ryan Specialty by 107.5% during the third quarter. JPMorgan Chase & Co. now owns 459,464 shares of the company’s stock worth $30,504,000 after buying an additional 238,064 shares during the last quarter. Bar Harbor Wealth Management increased its stake in shares of Ryan Specialty by 5.9% during the 4th quarter. Bar Harbor Wealth Management now owns 168,871 shares of the company’s stock worth $10,835,000 after purchasing an additional 9,482 shares during the last quarter. Barclays PLC increased its holdings in Ryan Specialty by 1.1% in the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company’s stock worth $108,994,000 after acquiring an additional 17,267 shares during the last quarter. Teachers Retirement System of The State of Kentucky raised its stake in Ryan Specialty by 51.5% in the 3rd quarter. Teachers Retirement System of The State of Kentucky now owns 30,760 shares of the company’s stock valued at $2,042,000 after acquiring an additional 10,460 shares during the period. Finally, GAMMA Investing LLC lifted its holdings in Ryan Specialty by 38.1% during the fourth quarter. GAMMA Investing LLC now owns 1,725 shares of the company’s stock valued at $111,000 after purchasing an additional 476 shares during the last quarter. 84.82% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Ryan Specialty

In other news, EVP Brendan Martin Mulshine sold 30,000 shares of the firm’s stock in a transaction that occurred on Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Nicholas Dominic Cortezi sold 35,000 shares of the company’s stock in a transaction on Friday, January 17th. The stock was sold at an average price of $67.15, for a total value of $2,350,250.00. Following the completion of the sale, the director now directly owns 25,809 shares in the company, valued at approximately $1,733,074.35. The trade was a 57.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 211,894 shares of company stock valued at $14,089,370 in the last 90 days. Insiders own 11.10% of the company’s stock.

Wall Street Analyst Weigh In

RYAN has been the subject of several recent research reports. UBS Group lifted their target price on shares of Ryan Specialty from $82.00 to $84.00 and gave the stock a “buy” rating in a research note on Wednesday, February 26th. TD Cowen assumed coverage on Ryan Specialty in a research report on Thursday, April 10th. They set a “buy” rating and a $89.00 price target for the company. Wells Fargo & Company decreased their price objective on shares of Ryan Specialty from $69.00 to $66.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 10th. Royal Bank of Canada decreased their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating on the stock in a report on Friday, February 21st. Finally, Barclays dropped their price objective on shares of Ryan Specialty from $88.00 to $83.00 and set an “overweight” rating for the company in a report on Friday. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $75.67.

Ryan Specialty Trading Up 2.0 %

NYSE RYAN opened at $74.24 on Tuesday. The stock has a 50-day moving average of $70.16 and a 200-day moving average of $68.94. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. Ryan Specialty Holdings, Inc. has a 1-year low of $48.48 and a 1-year high of $77.16. The firm has a market cap of $19.44 billion, a PE ratio of 107.60, a price-to-earnings-growth ratio of 1.19 and a beta of 0.66.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). The company had revenue of $663.53 million for the quarter, compared to analysts’ expectations of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. As a group, sell-side analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.

Ryan Specialty Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were issued a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 0.65%. The ex-dividend date was Tuesday, March 4th. This is an increase from Ryan Specialty’s previous quarterly dividend of $0.11. Ryan Specialty’s payout ratio is currently 69.57%.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.